Edition:
United Kingdom

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

1.16USD
3:25pm GMT
Change (% chg)

$0.01 (+0.87%)
Prev Close
$1.15
Open
$1.17
Day's High
$1.17
Day's Low
$1.16
Volume
1,001
Avg. Vol
23,234
52-wk High
$2.30
52-wk Low
$0.85

Select another date:

Thu, Feb 1 2018

BRIEF-Marrone Bio Innovations Says ‍Board Approved An Increase In Size Of Board To Seven People

* MARRONE BIO INNOVATIONS SAYS ‍ BOARD APPROVED AN INCREASE IN SIZE OF BOARD TO SEVEN PEOPLE - SEC FILING​ Source text: [http://bit.ly/2EthyhL] Further company coverage:

BRIEF-Marrone Bio Announces Stockholder Approval Of Private Placement, Debt Refinance Transactions

* MARRONE BIO INNOVATIONS, INC. ANNOUNCES STOCKHOLDER APPROVAL OF PRIVATE PLACEMENT AND DEBT REFINANCE TRANSACTIONS Source text for Eikon: Further company coverage:

BRIEF-Marrone Bio Innovations - Haven Sun Protectant Approved in California

* MARRONE BIO INNOVATIONS INC - ‍CALIFORNIA DEPARTMENT OF FOOD AND AGRICULTURE HAS APPROVED USE OF HAVEN​ Source text for Eikon: Further company coverage:

BRIEF-Marrone Bio Innovations ‍Signs Exclusive Distribution Agreement With Great Harvest Agri Chemicals Corp

* MARRONE BIO INNOVATIONS INC - ‍SIGNED AN EXCLUSIVE DISTRIBUTION AGREEMENT WITH GREAT HARVEST AGRI CHEMICALS CORPORATION​ Source text for Eikon: Further company coverage:

BRIEF-Marrone Bio And DISAGRO Sign Exclusive Distribution Agreement For Regalia Maxx Biofungicide In Central America

* MARRONE BIO INNOVATIONS AND DISAGRO SIGN EXCLUSIVE DISTRIBUTION AGREEMENT FOR REGALIA® MAXX BIOFUNGICIDE IN CENTRAL AMERICA Source text for Eikon: Further company coverage:

BRIEF-Marrone Bio Innovations, Inc. Announces Comprehensive Financing And Debt Restructuring Transaction

* MARRONE BIO INNOVATIONS, INC. ANNOUNCES COMPREHENSIVE FINANCING AND DEBT RESTRUCTURING TRANSACTION

BRIEF-Marrone Bio Innovations qtrly ‍basic, diluted net loss per common share $0.27​

* Marrone Bio Innovations, Inc reports third quarter 2017 financial results

BRIEF-Marrone Bio Innovations receives EPA approval for novel biofungicide

* Marrone Bio Innovations receives EPA approval for novel biofungicide

BRIEF-Marrone Bio signs exclusive agreement with Kenya Biologics

* Marrone Bio Innovations signs exclusive distribution agreement with Kenya Biologics Ltd. For Kenya and Tanzania

BRIEF-Marrone Bio Innovations receives positive results from Brazil trials

* Marrone Bio Innovations Inc receives positive results from Brazil trials

Select another date: